Status:
COMPLETED
Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study
Lead Sponsor:
West China Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-40 years
Brief Summary
The optimal surgical treatment option (BCS+RT versus MAST) for young patients with early-stage breast cancer remains debated. The present study aims to explore trends in surgical management and compar...
Detailed Description
This study is a unique addition to the current research on young women with early-stage breast cancer, aiming to compare the survival outcomes between BCS+RT and MAST, providing valuable insights into...
Eligibility Criteria
Inclusion
- Patients aged 18-40 years.
- Pathological diagnosis of invasive breast cancer.
- Undergoing Breast-Conserving Surgery (BCS) with Radiotherapy (RT) or Mastectomy (MAST).
- Availability of detailed clinical information, including:
- Tumor (T) stage. Node (N) stage. Clinical stage. Hormone receptor status. Endocrine therapy details. Targeted therapy details.
Exclusion
- Male patients.
- Patients with distant metastatic disease.
- Patients with bilateral breast cancer.
- Patients not undergoing surgery.
- Follow-up time of less than 1 month.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
974 Patients enrolled
Trial Details
Trial ID
NCT06603805
Start Date
January 1 2008
End Date
January 1 2024
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.